Neuro-Oncology Reviews
Volume
25 Number 22
30 November 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 22, 30 November
Begagić E, Pugonja R, Bečulić
H, Čeliković A, Tandir Lihić L, Kadić Vukas S,
Čejvan L, Skomorac R, Selimović E, Jaganjac B,
Juković-Bihorac F, Jusić A, Pojskić M.
Molecular
Targeted Therapies in Glioblastoma Multiforme: A Systematic
Overview of Global Trends and Findings.
Brain
Sci. 2023 Nov 17;13(11):1602∟.
doi: 10.3390/brainsci13111602∟.
PMID: 38002561∟.
Review. ˍ
Kumar N, Khurana B, Arora
D.
Nose-to-brain
drug delivery for the treatment of glioblastoma multiforme:
nanotechnological interventions.
Pharm
Dev Technol. 2023 Nov 17:1-16∟.
doi: 10.1080/10837450.2023.2285506∟.
PMID: 37975846∟.
Review˰ ˍ
Trevisi G, Mangiola A.
Current
Knowledge about the Peritumoral Microenvironment in
Glioblastoma.
Cancers
(Basel). 2023 Nov 17;15(22):5460∟.
doi: 10.3390/cancers15225460∟.
PMID: 38001721∟.
Review. ˍ
Brosque A, Friedmann-Morvinski
D.
Drivers
of heterogeneity in the glioblastoma immune microenvironment.
Curr
Opin Cell Biol. 2023 Nov 18;85:102279∟.
doi: 10.1016/j.ceb.2023.102279∟.
PMID: 37984008∟.
Review˰ ˍ
Fu AY, Kavia J, Yadava Y,
Srinivasan A, Hargwood P, Mazzola CA, Ammar A.
Biopsy
of diffuse midline glioma is safe and impacts targeted therapy: a
systematic review and meta-analysis.
Childs
Nerv Syst. 2023 Nov 18∟.
doi: 10.1007/s00381-023-06208-4∟.
PMID: 37980290∟.
Review, Meta-analysis˰ ˍ
Huang WZ, Chen HC, Chang TK, You
WC, Jan YJ, Chou YC.
Extracranial
metastasis of pediatric glioblastoma: case report and literature
review.
Childs
Nerv Syst. 2023 Nov 20∟.
doi: 10.1007/s00381-023-06229-z∟.
PMID: 37982875∟.
Case report, Review˰ ˍ
Picca A, Bruno F, Nichelli L,
Sanson M, Rudà R.
Advances
in molecular and imaging biomarkers in lower-grade gliomas.
Expert
Rev Neurother. 2023 Nov 20:1-15∟.
doi: 10.1080/14737175.2023.2285472∟.
PMID: 37982735∟.
Review˰ ˍ
Habibi MA, Aghaei F, Tajabadi Z,
Mirjani MS, Minaee P, Eazi S.
The
performance of Machine Learning for prediction of H3K27M Mutation
in Midline Gliomas; A Systematic Review and Meta-Analysis.
World
Neurosurg. 2023 Nov 22:S1878-8750(23)01624-8∟.
doi: 10.1016/j.wneu.2023.11.061∟.
PMID: 37995996∟.
Review, Meta-analysis˰ ˍ
Hoebel KV, Bridge CP, Ahmed S,
Akintola O, Chung C, Huang RY, Johnson JM, Kim A, Ly KI, Chang K,
Patel J, Pinho M, Batchelor TT, Rosen BR, Gerstner ER,
Kalpathy-Cramer J.
Expert-centered
Evaluation of Deep Learning Algorithms for Brain Tumor
Segmentation.
Radiol
Artif Intell.
2023 Nov 22;6(1):e220231. doi:
10.1148/ryai.220231. PMID:
38197800. Review. ˍ
Lan YL, Zou S, Wang W, Chen Q, Zhu
Y.
Progress
in cancer neuroscience.
MedComm
(2020). 2023 Nov 22;4(6):e431∟.
doi: 10.1002/mco2.431∟.
PMID: 38020711∟.
Review. ˍ
**
Chen E, Ling AL, Reardon DA,
Chiocca EA.
Lessons
learned from phase 3 trials of immunotherapy for glioblastoma:
Time for longitudinal sampling?
Neuro
Oncol. 2023 Nov 23:noad211∟.
doi: 10.1093/neuonc/noad211∟.
PMID: 37995317∟.
Review. ˍ
Malik JR, Podany AT, Khan P,
Shaffer CL, Siddiqui JA, Baranowska-Kortylewicz J, Le J, Fletcher
CV, Ether SA, Avedissian SN.
Chemotherapy
in pediatric brain tumor and the challenge of the blood-brain
barrier.
Cancer
Med. 2023 Nov 23∟.
doi: 10.1002/cam4.6647∟. PMID: 37997517∟. Review. ˍ
Picca A, Sansone G, Santonocito OS,
Mazzanti CM, Sanson M, Di Stefano AL.
Diffuse
Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks,
and Therapeutic Perspectives.
Cancers
(Basel). 2023 Nov 23;15(23):5555∟.
doi: 10.3390/cancers15235555∟.
PMID: 38067258∟.
Review. ˍ
Bo Y, Mu L, Yang Z, Li W, Jin
M.
Research
progress on ferroptosis in gliomas (Review).
Oncol
Lett. 2023 Nov 27;27(1):36∟.
doi: 10.3892/ol.2023.14169∟.
PMID: 38108075∟.
Review. ˍ
Andrews CE, Zilberberg J,
Perez-Olle R, Exley MA, Andrews DW.
Targeted
immunotherapy for glioblastoma involving whole tumor-derived
autologous cells in the upfront setting after craniotomy.
J
Neurooncol. 2023 Nov 29∟.
doi: 10.1007/s11060-023-04491-4∟.
PMID: 38017340∟.
Review.
ˍ
Riviere-Cazaux C, Carlstrom LP, Neth BJ, Olson IE, Rajani K,
Rahman M, Ikram S, Mansour MA, Mukherjee B, Warrington AE, Short
SC, von Zglinicki T, Brown DA, Burma S, Tchkonia T, Schafer MJ,
Baker DJ, Kizilbash SH, Kirkland JL, Burns TC.
An
untapped window of opportunity for glioma: targeting
therapy-induced senescence prior to recurrence.
NPJ
Precis Oncol. 2023 Nov 29;7(1):126∟.
doi: 10.1038/s41698-023-00476-8∟.
PMID: 38030881∟.
Review. ˍ
Kaina B.
Temozolomide,
Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas:
Update of Mechanisms, Drug Resistance and Therapeutic
Implications.
J
Clin Med. 2023 Nov 30;12(23):7442∟.
doi: 10.3390/jcm12237442∟.
PMID: 38068493∟.
Review. ˍ
Martinez PJ, Green AL, Borden
MA.
Targeting
diffuse midline gliomas: The promise of focused
ultrasound-mediated blood-brain barrier opening.
J
Control Release. 2023 Nov 30;365:412-421∟.
doi: 10.1016/j.jconrel.2023.11.037∟.
PMID: 38000663∟.
Review˰ ˍ